Staff Data Search - جامعة الزقازيق

Personal Website

Faculty pharmacy - Department Pharmaceutics Department

BSc In NULL, [2014]
MSc In NULL, [2018]
PhD In NULL, [2021]

قائم باجازة خاصة

Academic Jobs

معيد : 29/12/2014
Doctor Assisant : 25/11/2018
Doctor : 26/10/2021

Publications

1 - Upgrading of dissolution and anti-hypertensive effect of Carvedilol via two combined approaches: self-emulsification and liquisolid techniques (2018).

2 - Transdermal ethosomal gel nanocarriers; a promising strategy for enhancement of antihypertensive effect of carvedilol (2019).

3 - Self-emulsifying drug delivery formulations (2018).

4 - Optimization of injectable PLGA in-situ forming implants of anti-psychotic risperidone via Box-Behnken Design (2020).

5 - An overview of PLGA in-situ forming implants based on solvent exchange technique: effect of formulation components and characterization (2021).

6 - Morphological characterization of optimized risperidone-loaded in-situ gel forming implants with pharmacokinetic and behavioral assessments in rats (2021).

7 - Electrospun Nanofibers Revisited: An Update on the Emerging Applications in Nanomedicine (2022).

8 - Investigation of Alogliptin-Loaded In Situ Gel Implants by 23 Factorial Design with Glycemic Assessment in Rats (2022).

9 - Exosomes in Parkinson: revisiting their pathologic role and potential applications (2022).

10 - Development of depot PLGA-based in-situ implant of Linagliptin: Sustained release and glycemic control (2023).

11 - Soluplus® as a solubilizing excipient for poorly water-soluble drugs: Recent advances in formulation strategies and pharmaceutical product features (2023).

12 - Development of Carvedilol-Loaded Albumin-Based Nanoparticles with Factorial Design to Optimize In Vitro and In Vivo Performance (2023).

13 - Exploitation of transdermal nanobilosomal gel platforms for ameliorating anti-diabetic activity of empagliflozin following I-optimal design (2023).

14 - Optimization of Potential Nanoemulgels for Boosting Transdermal Glimepiride Delivery and Upgrading Its Anti-Diabetic Activity (2023).

15 - Tailoring Risperidone-Loaded Glycethosomal In Situ Gels Using Box–Behnken Design for Treatment of Schizophrenia-Induced Rats via Intranasal Route (2023).

16 - The Exploitation of pH-Responsive Eudragit-Coated Mesoporous Silica Nanostructures in the Repurposing of Terbinafine Hydrochloride for Targeted Colon Cancer Inhibition: Design Optimization, In Vitro Characterization, and Cytotoxicity Assessment (2023).

17 - Investigating the efficacy of mirtazapine-embedded invasomal gel nanocarriers via I-optimal design for management of atopic dermatitis (2024).

18 - Verapamil-Loaded Cubosomes for Enhancing Intranasal Drug Delivery: Development, Characterization, Ex Vivo Permeation, and Brain Biodistribution Studies (2024).

19 - The assessment of pharmacokinetics and neuroprotective effect of berberine hydrochloride-embedded albumin nanoparticles via various administration routes: comparative in-vivo studies in rats (2024).

20 - Evaluation of Mucoadhesive Nano-Bilosomal In Situ Gels Containing Anti-Psychotic Clozapine for Treatment of Schizophrenia: In Vitro and In Vivo Studies (2024).

21 - Fabrication and Optimization of a Silodosin In Situ-Forming PLGA Implants for the Treatment of Benign Prostatic Hyperplasia: In Vitro and In Vivo Study (2024).

Research Area